Drug intelligence / Profile preview

adapalene + doxycycline

Development stage
Unknown
Lead developer
Pontificia Universidad Católica de Chile
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

A combination therapy consisting of topical adapalene 0.1% gel and oral doxycycline 100 mg/day, utilized as the conventional therapy comparator in clinical research conducted by the Pontificia Universidad Católica de Chile. Adapalene is a naphthoic acid derivative with retinoid activity that selectively binds to nuclear retinoic acid receptors (RAR-beta and RAR-gamma), leading to the normalization of follicular epithelial cell differentiation and reduction of comedone formation. Doxycycline is a broad-spectrum tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit of susceptible bacteria, including Cutibacterium acnes, and provides additional anti-inflammatory benefits by inhibiting neutrophil chemotaxis and matrix metalloproteinases. This combination is a standard-of-care approach for moderate inflammatory acne vulgaris.

Other names
conventional therapyadapalene gel 0.1% plus doxycycline 100 mg/day
02

Targets

Bacterial RibosomeRARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)

Beyond the preview

Go deeper on adapalene + doxycycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adapalene + doxycycline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call